Gerald Edelman is thrilled to announce that its Deal Advisory team has advised the shareholders of Rocket Medical Group Limited (Rocket Medical), a UK based, award-winning designer and manufacturer of single-use medical devices, on the sale to Röko, a Sweden-based investment company, via a newly formed vehicle, RM Holdco Limited. Pricing and other deal terms have not been disclosed.
Röko has acquired Rocket Medical in partnership with members of the Bernberg family and management. Rocket Medical designs and manufactures single-use medical devices for clinical use in chest drainage, ascites drainage, reproductive medicine, obstetrics, and diagnostic medicine. It is headquartered in Watford, and has its production facility in Washington, Tyne & Wear, from where products are shipped to more than 50 countries. Since the start in 1964, Rocket Medical has been run by the Bernberg family with Robi Bernberg (2nd generation) having been the Managing Director since 1989. Rocket Medical has local subsidiaries in seven countries across three continents and employs over 240 people. Rocket Medical achieved revenue in excess of £26m in the latest fiscal year.
Röko is a Sweden-based investment company with €270m of capital and a portfolio of 12 companies in a variety of industries across Europe. The team has more than 80 years of combined experience of working with founder and entrepreneur-led companies across a broad range of industries.
Robi Bernberg, Managing Director of Rocket Medical, commented:
“We are absolutely thrilled to have completed the transaction with Röko. As a family-owned business, it was extremely important for the existing shareholders that this family feeling would continue with any investment partner that we chose. With their long-term vision and strategy, we are confident that we have found the perfect partner in Röko to enable Rocket to continue its exceptional growth and we can’t wait for the new adventure to begin.
The team at Gerald Edelman has done a fantastic job in not only identifying Röko as the perfect partner for us, but also in structuring and negotiating the deal and guiding us through the transaction. Their experience and advice has been invaluable and we are extremely grateful. We would absolutely recommend them to anyone considering an investment or sale of their business.”
Nick Wallis, Partner in Gerald Edelman’s Deal Advisory team, added:
“We are delighted to have successfully advised Robi and the other Rocket Medical shareholders on this landmark transaction. Rocket Medical has been around for nearly 60 years, and, as a family business, we knew how important it was to find the right partner for the team and we are confident that we have found that in Röko.
More broadly, this is an important transaction following the difficulties of lockdown and demonstrates the fact that cross-border M&A continues to thrive despite travel restrictions, and that our team at Gerald Edelman continues to lead the way in advising in the mid-market space. We wish all parties all the best for the future, and look forward to watching the Rocket Medical business continue to thrive.”Get in touch Back to top